Overview

• Discuss the burden of hyperkalemia in patients with CKD and heart failure, including recurrent hyperkalemia and risk of RAASi down-titration and discontinuation
• Discuss guideline recommendations for treatment of hyperkalemia in the setting of CKD and heart failure
• Review a potassium binder to treat hyperkalemia

SPONSORED BY

AstraZeneca